A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population

American Journal of the Medical Sciences

Volumn 334, Issue 3, 2007, Pages 184-189

  Yang, Wenjie ^a   Reynolds, Kristi ^a   Gu, Dongfeng ^c   Chen, Jing ^a,b   He, Jiang ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUWAI HOSPITAL   (China)

Author keywords

Agreement; Chinese; Cross sectional study; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; PREVALENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; URBAN POPULATION;

EID: 34548674461     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3180a6ed66     Document Type: Article

References (30)

1. Strong K, Mathers C, Leeder S, et al. Preventing chronic diseases: how many lives can we save? Lancet 2005;366:1578-82.
2. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis of observational studies. Am J Med 2006;119:812-9.
3. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
5. Anand SS, Yi Q, Gerstein H, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003;108:420-5.
6. Further Study of Risk Factors for Stroke and Coronary Heart Disease group: the prevalence of the metabolic syndrome in a 11 provinces cohort in China. Chin J Prev Med 2002;36:298-300.
7. Gu D, Reynolds K, Duan X, et al. InterASIA Collaborative Group: prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46:1190-8.
8. He J, Gu D, Reynolds K, et al. InterASIA Collaborative Group: serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004;110:405-11.
9. Gu D, Reynolds K, Wu X, et al. InterASIA Collaborative Group: International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920-7.
10. Gu D, Reynolds K, Wu X, et al. InterASIA Collaborative Group: prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398-405.
11. IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed June 7, 2005.
12. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications; report of a WHO consultation. Geneva: WHO; 1999.
13. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington, DC: US Government Printing Office; 2001.
14. He J, Neal B, Gu D, et al. International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. Ethn Dis 2004;14:260-8.
15. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-70.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Donner A, Eliasziw M, Klar N. Testing the homogeneity of kappa statistics. Biometrics 1996;52:176-83.
18. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
19. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-74.
20. Tan CE, Ma S, Wai D, et al. Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-6.
21. DECODA Study Group. Prevalence of the metabolic syndrome in populations of Asian origin comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 2006.Epub ahead of print.
22. Ko GT, Cockram CS, Chow CC, et al. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract 2006;73:58-64.
23. He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006;47:1588-94.
24. Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care 2005;28:2745-9.
25. DECODA Study Group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-46.
26. Athyros VG, Ganotakis ES, Elisaf MS, et al. Prevalence of vascular disease in metabolic syndrome using 3 proposed definitions. Int J Cardiol 2006 (Epub ahead of print).
27. Lu B, Yang YH, Song XY, et al. An evaluation of the international diabetes federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 2006;55:1088-96.
28. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-94.
29. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.
30. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.